| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581771 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 8 Pages |
Abstract
The significant variability in treatments used for PTCL emphasizes the lack of consensus therapy in this rarer lymphoma and calls for additional organized prospective and registry studies to evaluate comparative effectiveness.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Tatyana Feldman, Charles M. Farber, Kelly Choi, Claudio Faria, Andre Goy, Jacqueline Connors, Dhakshila Paramanathan, Sukhi Kaur, Eric Schultz, Michael McGuire, Stuart L. Goldberg,